183 related articles for article (PubMed ID: 15013872)
21. [Photodynamic therapy carefully destroys neovascularization of the retina].
Ophthalmologe; 2003 Feb; 100(2):1 p following 174. PubMed ID: 12650171
[No Abstract] [Full Text] [Related]
22. Combination therapy with verteporfin and anti-VEGF agents in neovascular age-related macular degeneration: where do we stand?
Kaiser PK
Br J Ophthalmol; 2010 Feb; 94(2):143-5. PubMed ID: 20139287
[No Abstract] [Full Text] [Related]
23. [New methods of treatment of age-related macular degeneration. Photodynamic therapy. Part I].
Gierek-Łapińska A; Wykrota H; Trzciakowski K
Klin Oczna; 2002; 104(3-4):276-82. PubMed ID: 12608319
[TBL] [Abstract][Full Text] [Related]
24. Verteporfin therapy combined with intravitreal triamcinolone in all types of choroidal neovascularization due to age-related macular degeneration.
Augustin AJ; Schmidt-Erfurth U
Ophthalmology; 2006 Jan; 113(1):14-22. PubMed ID: 16360209
[TBL] [Abstract][Full Text] [Related]
25. Choroidal neovascular membranes treated with photodynamic therapy.
Arroyo JG; Michaud N; Jakobiec FA
Arch Ophthalmol; 2003 Jun; 121(6):898-903. PubMed ID: 12796267
[No Abstract] [Full Text] [Related]
26. Prognosis for placebo-treated eyes in VIP report 2.
Da Pozzo S; Parodi MB
Am J Ophthalmol; 2002 Feb; 133(2):294-6. PubMed ID: 11812454
[No Abstract] [Full Text] [Related]
27. Photodynamic therapy for inflammatory CNV: do we know enough?
Kramer M
Ocul Immunol Inflamm; 2005; 13(5):331-3. PubMed ID: 16419418
[No Abstract] [Full Text] [Related]
28. Treatment of subfoveal choroidal neovascularisation in age related macular degeneration: focus on clinical application of verteporfin photodynamic therapy.
Soubrane G; Bressler NM
Br J Ophthalmol; 2001 Apr; 85(4):483-95. PubMed ID: 11264143
[No Abstract] [Full Text] [Related]
29. Guidelines for PDT in Japan.
Tano Y;
Ophthalmology; 2008 Mar; 115(3):585-585.e6. PubMed ID: 18319105
[No Abstract] [Full Text] [Related]
30. [Photodynamic therapy of age-related macular degeneration].
Jaakkola A
Duodecim; 2002; 118(8):813-9. PubMed ID: 12238196
[No Abstract] [Full Text] [Related]
31. Photodynamic therapy with verteporfin in patients with age-related macular degeneration and juxtafoveal choroidal neovascularization.
Frennesson CI
Acta Ophthalmol Scand; 2004 Dec; 82(6):651-5. PubMed ID: 15606459
[TBL] [Abstract][Full Text] [Related]
32. Photodynamic therapy for choroidal neovascularization.
Schachat AP
Ophthalmologica; 2001; 215 Suppl 2():27-36; discussion, 42-3. PubMed ID: 11740161
[No Abstract] [Full Text] [Related]
33. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group.
Arch Ophthalmol; 1999 Oct; 117(10):1329-45. PubMed ID: 10532441
[TBL] [Abstract][Full Text] [Related]
34. [Photodynamic therapy with Visudyne in macular degeneration associated with subfoveal classical choroidal neovascularization].
Soucek P; Boguzsaková J; Cihelková I
Cesk Slov Oftalmol; 2002 Apr; 58(2):89-97. PubMed ID: 12046251
[TBL] [Abstract][Full Text] [Related]
35. Encouraging results of photodynamic therapy with Visudyne in a clinical patient material of age-related macular degeneration.
Frennesson CI; Nilsson SE
Acta Ophthalmol Scand; 2004 Dec; 82(6):645-50. PubMed ID: 15606458
[TBL] [Abstract][Full Text] [Related]
36. Photodynamic therapy for occult choroidal neovascularization with pigment epithelium detachment in age-related macular degeneration.
Axer-Siegel R; Ehrlich R; Rosenblatt I; Kramer M; Priel E; Yassur Y; Weinberger D
Arch Ophthalmol; 2004 Apr; 122(4):453-9. PubMed ID: 15078661
[TBL] [Abstract][Full Text] [Related]
37. Photodynamic therapy for subfoveal choroidal neovascularization.
Tecnologica MAP Suppl; 2000 Sep; ():21-5. PubMed ID: 11503675
[No Abstract] [Full Text] [Related]
38. Verteporfin therapy of subfoveal minimally classic choroidal neovascularization in age-related macular degeneration: 2-year results of a randomized clinical trial.
Azab M; Boyer DS; Bressler NM; Bressler SB; Cihelkova I; Hao Y; Immonen I; Lim JI; Menchini U; Naor J; Potter MJ; Reaves A; Rosenfeld PJ; Slakter JS; Soucek P; Strong HA; Wenkstern A; Su XY; Yang YC;
Arch Ophthalmol; 2005 Apr; 123(4):448-57. PubMed ID: 15824216
[TBL] [Abstract][Full Text] [Related]
39. Photodynamic therapy with verteporfin: a new treatment in ophthalmology.
Michels S; Schmidt-Erfurth U
Semin Ophthalmol; 2001 Dec; 16(4):201-6. PubMed ID: 15513441
[TBL] [Abstract][Full Text] [Related]
40. Combined photodynamic therapy with verteporfin and intravitreal bevacizumab for choroidal neovascularization in age-related macular degeneration.
Dhalla MS; Shah GK; Blinder KJ; Ryan EH; Mittra RA; Tewari A
Retina; 2006; 26(9):988-93. PubMed ID: 17151484
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
